Organoid Platform Uncovers mITGB2 as a Promising CD4-Targeting Neoantigen in Liver Cancer
Using patient-derived hepatocellular carcinoma organoids, researchers identified mITGB2, a splice-variant-derived peptide presented by MHC class II, as a functionally immunogenic ...
